Skip to main content

Table 6 Haplotypic analysis of ESR1, ESR2, and UGT1A4 polymorphisms

From: Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study

Haplotype

Frequency of block

Frequency ratio (case:control)

(%)

Odds ratio

(95% CI)

P-value

ESR1 and ESR2 Block (rs3020410, rs3798577, rs1256049, rs2234693, and rs9340799)

 CTCCG

0.2417

0.2761: 0.232

1:00

N.A

 CTCTA

0.2358

0.2172: 0.2345

0.90 (0.56–1.45)

0.66

 CCCCG

0.1957

0.2025: 0.1681

0.61 (0.35–1.04)

0.071

 CCCTA

0.1702

0.2008: 0.1538

0.65 (0.42–1.02)

0.061

 ACCTA

0.0355

0.0266: 0.0391

0.73 (0.27–1.94)

0.53

 ATCTA

0.0355

0.0414: 0.0382

1.16 (0.46–2.89)

0.76

 CCCCA

0.0277

0.0291: 0.0274

0.80 (0.31–2.04)

0.64

 CTCCA

0.0186

0.0168: 0.0194

0.81 (0.22–2.92)

0.74

Global haplotype association p-value: 0.47

UGT1A4 Block (rs12468274, rs2011425, and rs6755571)

  TTC

0.8552

0.8557:0.8548

1.00

N.A

  CGC

0.0771

0.0726: 0.0816

1.12 (0.65–1.92)

0.69

  TTA

0.0526

0.0501:0.0551

1.07 (0.59–1.95)

0.82

  TGC

0.0118

0.019: 0.0048

0.25 (0.05–1.21)

0.086

Global haplotype association p-value: 0.39